Regulatory PathRegulatory requirements compared

Active substance

Captopril

Open in the medicines table

SFDA Saudi Arabia — SFDA human drug list

Trade nameStrengthForm · routePackPublic priceTypeCompanyStatus
ACETAB 25 MG TABLETS25 mgTablet · Oral use30 BlisterSAR 20.25Generic · PrescriptionKUWAIT SAUDI PHARMACEUTICAL INDUSTRIESValid
ACETAB 50 MG TABLETS50 mgTablet · Oral use30 BlisterSAR 34.20Generic · PrescriptionKUWAIT SAUDI PHARMACEUTICAL INDUSTRIESValid
Acetab1 mg/mlOral solution · Oral use1 BottleSAR 133.40Generic · PrescriptionKUWAIT SAUDI PHARMACEUTICAL INDUSTRIESValid
CAPOCARD 25MG TAB25 mgTablet · Oral use20 BlisterSAR 15.15Generic · PrescriptionDAR ALDAWAValid
CAPOCARD 50MG TAB50 mgTablet · Oral use20 BlisterSAR 25.40Generic · PrescriptionDAR ALDAWAValid
CAPRIL 25MG TAB25 mgTablet · Oral use20 BlisterSAR 18.65Generic · PrescriptionSPIMACO ADDWAEIHValid
CAPRIL 50MG TAB50 mgTablet · Oral use20 BlisterSAR 31.55Generic · PrescriptionSPIMACO ADDWAEIHValid
NOYADA 25MG/5ML ORAL SOLUTION5 mgOral solution · Oral use1 BottleSAR 165.00NCE · PrescriptionMACARTHYS LABORATORIES Ltd T/A MARTINDALE PHARMACEUTICALSValid
NOYADA 5MG/5ML ORAL SOLUTION1 mgOral solution · Oral use1 BottleSAR 140.40NCE · PrescriptionMACARTHYS LABORATORIES Ltd T/A MARTINDALE PHARMACEUTICALSValid
CAPOTEN 25MG TAB25 mgTablet · Oral use20 BlisterSAR 18.65NCE · PrescriptionSPIMACO ADDWAEIHWithdrawn by MAH · Not Marketed
CAPOTEN 50MG TAB50 mgTablet · Oral use20 BlisterSAR 31.55NCE · PrescriptionSPIMACO ADDWAEIHWithdrawn by MAH · Not Marketed
CAPTOPHAR 25MG TABLETS25 mgTablet · Oral use30 BlisterSAR 17.80Generic · PrescriptionGulf Pharmaceutical Industries (Julphar)Withdrawn by MAH · Not Marketed
CAPTOPHAR 50MG TABLETS50 mgTablet · Oral use28 BlisterSAR 28.10Generic · PrescriptionGulf Pharmaceutical Industries (Julphar)Withdrawn by MAH · Not Marketed
NOVO-CAPTORIL 12.5MG TAB12.5 mgTablet · Oral use20 BlisterSAR 11.55Generic · PrescriptionNOVOPHARMWithdrawn by MAH · Not Marketed
NOVO-CAPTORIL 25MG TAB25 mgTablet · Oral use20 BlisterSAR 18.25Generic · PrescriptionNOVOPHARMWithdrawn by MAH · Not Marketed
NOVO-CAPTORIL 50MG TAB50 mgTablet · Oral use20 BlisterSAR 29.10Generic · PrescriptionNOVOPHARMWithdrawn by MAH · Not Marketed
Indications — CHI Daman Drug Formulary

CARDIOMYOPATHY; CHRONIC KIDNEY DISEASE; CONGESTIVE HEART FAILURE; CORONARY ARTERY DISEASE; HYPERTENSION; NON-ST WAVE ELEVATED MYOCARDIAL INFARCTION (NSTEMI); SICKLE CELL DISEASE - ALBUMINURIA MANAGEMENT; ST-WAVE ELEVATED MYOCARDIAL INFARCTION (STEMI)

US FDA United States — FDA approvals (Drugs@FDA)

ProductStrengthForm · routeApplicantStatusFirst approved
CAPTOPRIL12.5MG; 25MG; 50MG; 100MGtablet · oralPRINSTON INCPrescription13 Feb 1996
CAPTOPRIL12.5MG; 25MG; 50MG; 100MGtablet · oralHIKMA INTL PHARMSPrescription13 Feb 1996
CAPTOPRIL12.5MG; 25MG; 50MG; 100MGtablet · oralWOCKHARDT BIO AGPrescription28 Mar 1997
CAPTOPRIL50MG; 25MG; 100MG; 12.5MGtablet · oralANDAS 5 HOLDINGPrescription30 May 1997
CAPTOPRIL12.5MG; 25MG; 50MG; 100MGtablet · oralCOREPHARMAPrescription28 Oct 1998
CAPTOPRIL12.5MG; 25MG; 50MG; 100MGtablet · oralAJANTA PHARMA LTDPrescription13 Dec 2019
CAPTOPRIL12.5MG; 25MG; 50MG; 100MGtablet · oralAIPING PHARM INCPrescription27 Jan 2023
CAPOTEN50MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**; 25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**; 100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**; 150MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**; 12.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**; 37.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**; 75MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**tablet · oralAARXION ANDA HLDINGDiscontinued6 Apr 1981
CAPTOPRIL12.5MG; 25MG; 50MG; 100MGtablet · oralAPOTHECONDiscontinued31 Mar 1995
CAPTOPRIL12.5MG; 25MG; 50MG; 100MGtablet · oralCHARTWELL RXDiscontinued9 Nov 1995
CAPTOPRIL12.5MG; 25MG; 50MG; 100MGtablet · oralTEVADiscontinued13 Feb 1996
CAPTOPRIL12.5MG; 25MG; 50MG; 100MGtablet · oralTP ANDA HOLDINGSDiscontinued13 Feb 1996
CAPTOPRIL12.5MG; 25MG; 50MG; 100MGtablet · oralDAVA PHARMS INCDiscontinued13 Feb 1996
CAPTOPRIL12.5MG; 25MG; 50MG; 100MGtablet · oralCOSETTE PHARMS NCDiscontinued13 Feb 1996
CAPTOPRIL12.5MG; 25MG; 50MG; 100MGtablet · oralAUROBINDO PHARMA USADiscontinued13 Feb 1996
CAPTOPRIL12.5MG; 25MG; 50MG; 100MGtablet · oralWATSON LABSDiscontinued13 Feb 1996
CAPTOPRIL12.5MG; 25MG; 50MG; 100MGtablet · oralCOSETTE PHARMS NCDiscontinued13 Feb 1996
CAPTOPRIL12.5MG; 25MG; 50MG; 100MGtablet · oralSANDOZDiscontinued13 Feb 1996
CAPTOPRIL12.5MG; 25MG; 50MG; 100MGtablet · oralCOSETTE PHARMS NCDiscontinued13 Feb 1996
CAPTOPRIL12.5MG; 25MG; 50MG; 100MGtablet · oralSTRIDES PHARMA INTLDiscontinued13 Feb 1996
CAPTOPRIL12.5MG; 25MG; 50MG; 100MGtablet · oralCHARTWELL RXDiscontinued13 Feb 1996
CAPTOPRIL12.5MG; 25MG; 50MG; 100MGtablet · oralWATSON LABSDiscontinued23 Apr 1996
CAPTOPRIL12.5MG; 25MG; 50MG; 100MGtablet · oralWATSON LABSDiscontinued23 May 1996
CAPTOPRIL50MG; 25MG; 100MG; 12.5MGtablet · oralG AND W LABS INCDiscontinued30 Aug 1996
CAPTOPRIL50MG; 25MG; 100MG; 12.5MGtablet · oralEGIS PHARMSDiscontinued29 May 1997

2 more — full table

Canada Canada — marketed products (Health Canada)

BrandDINStrengthForm · routeCompany
APO-CAPTO TAB 100MG00893625100 MGTABLET · ORALAPOTEX INC
APO-CAPTO TAB 12.5MG0089359512.5 MGTABLET · ORALAPOTEX INC
APO-CAPTO TAB 50MG0089361750 MGTABLET · ORALAPOTEX INC
NOYADA025439075 MG / 5 MLSOLUTION · ORALETHYPHARM INC
NOYADA0254391525 MG / 5 MLSOLUTION · ORALETHYPHARM INC
TEVA-CAPTOPRIL0194296412.5 MGTABLET · ORALTEVA CANADA LIMITED
TEVA-CAPTOPRIL0194297225 MGTABLET · ORALTEVA CANADA LIMITED
TEVA-CAPTOPRIL0194298050 MGTABLET · ORALTEVA CANADA LIMITED
TEVA-CAPTOPRIL01942999100 MGTABLET · ORALTEVA CANADA LIMITED

Prices — United States and England

SourceProduct as listedPriceUnit / packDate
US NADACCAPTOPRIL 100 MG TABLET$0.32292per EA2 Sep 2026
US NADACCAPTOPRIL 12.5 MG TABLET$0.22839per EA23 Sep 2026
US NADACCAPTOPRIL 25 MG TABLET$0.17282per EA23 Sep 2026
US NADACCAPTOPRIL 50 MG TABLET$0.36903per EA23 Sep 2026
NHS Drug TariffCaptopril 12.5mg tablets£28.1756 tablet1 Oct 2026
NHS Drug TariffCaptopril 25mg tablets£57.6356 tablet1 Oct 2026
NHS Drug TariffCaptopril 25mg/5ml oral solution sugar free£101.00100 ml1 Oct 2026
NHS Drug TariffCaptopril 50mg tablets£55.1356 tablet1 Oct 2026
NHS Drug TariffCaptopril 5mg/5ml oral solution sugar free£93.30100 ml1 Oct 2026

NADAC: average price US retail pharmacies pay to buy the medicine. NHS Drug Tariff Part VIIIA: basic price reimbursed to pharmacies in England and Wales.

Safety signals and safety-related labeling changes

All safety entries for captopril →

Combinations containing Captopril

Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.